echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > J Clin Invest: Fractional laser resurfacing treatment can effectively reduce the risk of non-melanoma skin cancer in aging skin

    J Clin Invest: Fractional laser resurfacing treatment can effectively reduce the risk of non-melanoma skin cancer in aging skin

    • Last Update: 2021-12-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    During human aging, the expression level of insulin-like growth factor 1 (IGF-1) in aging dermal fibroblasts decreases, which is related to the increased risk of non-melanoma skin cancer (NMSC)
    .


    Recently, researchers from the United States have explored the mechanism by which IGF-1 signaling affects photocarcinogenesis during chronic UVB exposure to determine whether Fractional Laser Resurfacing (FLR) of elderly skin that raises dermal IGF-1 levels can prevent actinization.


    The researchers established a human skin/ immune- deficient mouse xenograft model to test the effect of small molecule inhibitors of IGF-1 receptors on chronic UVB radiation
    .


    Subsequently, the researchers included human subjects 65 years and older to test the durability of FLR treatment


    immunity

    The results showed that the topical use of IGF-1R inhibitors to treat chronic UVB resulted in carcinogenic reactions
    .


    A single FLR treatment restores the proper UVB response in elderly skin very long lasting, at least 2 years


    In summary, the results of this study show that the elimination of senescent fibroblasts through FLR reduces the carcinogenic response of elderly skin to UVB
    .


    Therefore, trauma therapy is a potentially effective preventive measure for managing high-risk groups .

    Management prevention

     

    Original source:

     

    Dan F Spandau, et al.


    , Randomized controlled trial of fractionated laser resurfacing on aged skin as prophylaxis against actinic neoplasia .


    Randomized controlled trial of fractionated laser resurfacing on aged skin as prophylaxis against actinic neoplasia in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.